GSK Price to Free Cash Flow Ratio 2010-2022 | GSK

Historical price to free cash flow ratio values for GSK (GSK) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GSK Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2023-02-03 34.83 6.86
2022-09-30 29.15 $5.08 5.74
2022-06-30 53.31 $6.21 8.59
2022-03-31 52.93 $6.20 8.54
2021-12-31 52.82 $4.76 11.10
2021-09-30 45.20 $4.58 9.86
2021-06-30 46.53 $3.48 13.36
2021-03-31 41.15 $4.26 9.66
2020-12-31 41.66 $4.64 8.98
2020-09-30 42.04 $4.48 9.38
2020-06-30 45.02 $5.36 8.40
2020-03-31 41.34 $4.56 9.06
2019-12-31 50.60 $4.36 11.61
2019-09-30 45.44 $4.91 9.26
2019-06-30 42.13 $4.74 8.89
2019-03-31 43.47 $4.72 9.20
2018-12-31 39.16 $4.86 8.05
2018-09-30 40.69 $3.92 10.39
2018-06-30 40.34 $3.79 10.66
2018-03-31 38.62 $3.55 10.87
2017-12-31 34.44 $3.69 9.34
2017-09-30 38.87 $2.99 12.99
2017-06-30 40.76 $2.64 15.46
2017-03-31 39.40 $2.29 17.21
2016-09-30 39.29 $2.51 15.66
2016-06-30 39.07 $1.78 21.95
2016-03-31 36.13 $-7.04 0.00
2015-12-31 34.86 $1.00 34.99
2015-09-30 32.78 $1.75 18.78
2015-06-30 35.05 $2.39 14.64
2015-03-31 38.33 $10.99 3.49
2014-12-31 34.99 $3.42 10.24
2014-09-30 37.13 $3.52 10.53
2014-06-30 42.61 $4.13 10.31
2014-03-31 42.09 $4.79 8.78
2013-12-31 41.50 $4.98 8.33
2013-09-30 38.54 $4.65 8.29
2013-06-30 37.98 $2.83 13.40
2013-03-31 35.27 $2.91 12.10
2012-12-31 32.19 $2.78 11.60
2012-09-30 33.78 $2.94 11.47
2012-06-30 32.92 $4.64 7.09
2012-03-31 32.06 $4.36 7.35
2011-12-31 31.98 $4.33 7.38
2011-09-30 28.58 $3.85 7.43
2011-06-30 29.34 $2.94 9.97
2011-03-31 25.96 $3.56 7.28
2010-12-31 26.08 $4.38 5.96
2010-09-30 25.95 $4.59 5.65
2010-06-30 22.05 $5.69 3.87
2010-03-31 24.66 $5.29 4.66
2009-12-31 26.64 $4.84 5.51
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $71.300B $36.279B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00